Daiichi Sankyo - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeDaiichi Sankyo
Daiichi Sankyo logo

Daiichi Sankyo

0 followers

4568

Performance

About Daiichi Sankyo

Daiichi Sankyo is a global pharmaceutical company focused on researching, developing, and bringing medicines to patients across multiple therapeutic areas. The company emphasizes pipelines in areas such as oncology and cardiovascular diseases, and engages in open innovation and clinical trial transparency to advance medical science. With operations and research activities spanning international markets, Daiichi Sankyo aims to improve patient outcomes through innovative therapies and responsible governance.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Lerryn Trzcinski

Vice President, U.S. Market Access

Rich Jones

Vice President, Global Oncology Business Strategy & Analytics

Dalal Nesheiwat, PharmD

Head of R&D Operations

Mila Tartakovsky

Head of US Finance and Global Oncology Finance

Brian Hauser

Vice President, US Sales

Key Facts

HQ Location

Tokyo, Japan

Founded

2007

Employees

1K-5K

Status

Public

Website

https://daiichisankyo.com